Sponsorship, Authorship, and Accountability

  1. Covance Inc.;
  2. ICON Clinical Research;
  3. Inveresk Research Group;
  4. Kendle International Inc.;
  5. PAREXEL International Corp.;
  6. PPD Development; and
  7. Quintiles Transnational Corp.
  1. Princeton, NJ 08540 Dublin 18, Ireland Tranent EH33 2NE, Scotland Cincinnati, OH 45202 Waltham, MA 02451-1163 Wilmington, NC 28412 Durham, NC 27703

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR: …

    This 100-word excerpt has been provided in the absence of an abstract.

    « Previous | Next Article »Table of Contents